First Wave BioPharma Inc (FWBI) is down 6.89% Friday In Premarket Trading

First Wave BioPharma Inc (FWBI) is down Friday morning, with the stock losing -6.89% in pre-market trading to 5. FWBI's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 99 out of 146 industries, FWBI ranks higher than 0% of stocks. First Wave BioPharma Inc has risen 7.62% over the past month, closing at $5.23 on February 16. During this period of time, the stock fell as low as $4.96 and as high as $9.35. FWBI has an average analyst recommendation of Strong Buy. The company has an average price target of $40.00.

FWBI has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on FWBI!

See Full FWBI Report

First Wave BioPharma Inc has a Long-Term Technical rank of 27. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 73% of the market scoring higher. In the Biotechnology industry which is number 74 by this metric, FWBI ranks better than 74% of stocks.

Important Dates for Investors in FWBI:

-First Wave BioPharma Inc is set to release earnings on 2024-03-18. Over the last 12 months, the company has reported EPS of $1131.40. -We do not have a set dividend date for First Wave BioPharma Inc at this time. Click Here To Get The Full Report on First Wave BioPharma Inc (FWBI)